LPL Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $358K | Buy |
9,840
+327
| +3% | +$11.9K | ﹤0.01% | 4550 |
|
|
2025
Q1 | $344K | Buy |
9,513
+1,430
| +18% | +$51.8K | ﹤0.01% | 4392 |
|
|
2024
Q4 | $340K | Sell |
8,083
-287
| -3% | -$12.1K | ﹤0.01% | 4321 |
|
|
2024
Q3 | $465K | Buy |
8,370
+2,299
| +38% | +$128K | ﹤0.01% | 3994 |
|
|
2024
Q2 | $250K | Sell |
6,071
-1,131
| -16% | -$46.5K | ﹤0.01% | 4316 |
|
|
2024
Q1 | $336K | Sell |
7,202
-12
| -0.2% | -$560 | ﹤0.01% | 4046 |
|
|
2023
Q4 | $345K | Sell |
7,214
-179
| -2% | -$8.56K | ﹤0.01% | 3930 |
|
|
2023
Q3 | $264K | Sell |
7,393
-41
| -0.6% | -$1.46K | ﹤0.01% | 3978 |
|
|
2023
Q2 | $343K | Buy |
7,434
+1,446
| +24% | +$66.7K | ﹤0.01% | 3695 |
|
|
2023
Q1 | $240K | Buy |
5,988
+127
| +2% | +$5.09K | ﹤0.01% | 3888 |
|
|
2022
Q4 | $272K | Buy |
+5,861
| New | +$272K | ﹤0.01% | 3704 |
|
|
2022
Q3 | – | Sell |
-5,412
| Closed | -$323K | – | 4457 |
|
|
2022
Q2 | $323K | Buy |
5,412
+3
| +0.1% | +$179 | ﹤0.01% | 3548 |
|
|
2022
Q1 | $393K | Buy |
5,409
+2,457
| +83% | +$179K | ﹤0.01% | 3361 |
|
|
2021
Q4 | $248K | Buy |
2,952
+537
| +22% | +$45.1K | ﹤0.01% | 3822 |
|
|
2021
Q3 | $218K | Buy |
2,415
+22
| +0.9% | +$1.99K | ﹤0.01% | 3877 |
|
|
2021
Q2 | $228K | Sell |
2,393
-289
| -11% | -$27.5K | ﹤0.01% | 3789 |
|
|
2021
Q1 | $305K | Buy |
2,682
+15
| +0.6% | +$1.71K | ﹤0.01% | 3447 |
|
|
2020
Q4 | $369K | Buy |
+2,667
| New | +$369K | ﹤0.01% | 3024 |
|